Outlook Therapeutics OTLK
NASDAQ OTLK
$0.59 +0.02 (+3.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Price to Sales (2016 - 2025)

Updated

Outlook Therapeutics' Price to Sales came in at 4.70 for fiscal Q4 2025 (quarter ended Sep 30, 2025), down 42.0% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Price to Sales (2016 - 2025) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Price to Sales was 26.09.

  • The fiscal Q4 2025 figure represents the lowest quarterly Price to Sales since fiscal Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Outlook Therapeutics 80.68 Mn 44.93 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.70
Jun 30, 2025 8.10
Sep 30, 2019 3.33
Jun 30, 2019 15.62
Mar 31, 2019 26.76
Dec 31, 2018 12.58
Sep 30, 2018 12.52
Jun 30, 2018 5.59
Mar 31, 2018 4.82
Dec 31, 2017 7.75
Sep 30, 2017 8.96
Jun 30, 2017 17.56
Mar 31, 2017 40.47
Dec 31, 2016 31.03
Sep 30, 2016 24.55
Jun 30, 2016 21.47
API Access

Outlook Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=OTLK&period=max&api_key=YOUR_API_KEY